Mon–Thu 8am–4:30pm CT · Fri 8am–3pm CT
Clinical Trial · NCT00003763
Overview
RATIONALE: Diagnostic procedures using the drug radiolabeled folic acid and imaging may be effective in detecting ovarian cancer. PURPOSE: Diagnostic trial to study the effectiveness of radiolabeled folic acid plus imaging in detecting ovarian cancer.
Sponsor
Endocyte
Phase
N/A
Contacts
David M. Gershenson, MD (STUDY_CHAIR)
ClinicalTrials.gov
NCT00003763Help us improve your experience